Diets enriched in docosahexaenoic acid, a major n-3 fatty acid in fish oil, have hypotensive properties. One mechanism that can lower blood pressure is the direct dilation of arterioles by docosahexaenoic metabolites. Vascular endothelium contains cytochrome P-450 epoxygenases that transform the n-6 fatty acid arachidonate into epoxyeicosatrienoic acids (EETs), potent dilators of coronary arterioles and activators of large-conductance calcium-activated potassium (BK Ca ) channels. To test whether analogous activations occur for docosahexaenoate, we compared the potency of docosahexaenoate and its five cytochrome P-450 epoxygenase metabolites, epoxydocosapentaenoates (EDPs), in dilating porcine coronary arterioles (Ͻ135 m in diameter) precontracted with endothelin. The five EDP regioisomers had dilation EC 50 values ranging from 0
13,14-dihydroxydocosapentaenoic acid (13,14-DHDP) had an EC 50 value of 30 Ϯ 22 nM (n ϭ 7), whereas docosahexaenoate only dilated vessels at Ն1.0 M (n ϭ 7). Using patch-clamp techniques in the inside-out configuration, we determined that the 13,14-EDP regioisomer potently activated (EC 50 value of 6.6 Ϯ 0.6 pM; n ϭ 5) BK Ca channels in myocytes from the porcine coronary arterioles. Moreover, 13,14-EDP potently activated BK Ca channels in myocytes from rat coronary small arteries (150 -300 m in diameter); with an EC 50 value of 2.2 Ϯ 0.6 pM (n ϭ 7), 13,14-EDP was 1000-fold more potent than EETs in activating BK Ca channels. We conclude that EDPs potently dilate coronary microvessels and are the most potent fatty epoxides known to activate BK Ca channels in coronary smooth muscle cells. Both actions may contribute to the hypotensive effects of dietary fish oils.
Docosahexaenoate and eicosapentaenoate are the major n-3 fatty acids in fish oils. For over 20 years, dietary supplements with fish oils have been considered as indirectly cardioprotective because of their antithrombotic, antiatherosclerotic, and antihypertensive properties. Recent clinical studies suggest that docosahexaenoate may be the active agent in dietary fish oils responsible for lowering systemic blood pressure. In 1989, the daily ingestion of fish oil (5 g of docosahexaenoate and 10 g of eicosapentaenoate) was shown to reduce the blood pressure of patients with essential hypertension (Knapp and FitzGerald, 1989) . These antihypertensive effects, which follow eating large amounts of fish oil containing a low docosahexaenoate/eicosapentaenoate ratio, are now widely accepted (Appel et al., 1993; Morris et al., 1993) . Recently, the daily ingestion of fish containing small amounts of n-3 fatty acids (3.65 g) with a high docosahexaenoate/eicosapentaenoate ratio was also found to be antihypertensive (Mori et al., 1999) . Moreover, daily ingestions of 4.0 g of docosahexaenoate reduced blood pressure in normotensive subjects (Mori et al., 2000) . Together, these clinical studies raised the possibility that dietary docosahexaenoate has hypotensive effects.
Epoxyeicosatrienoic acids (EETs) are cytochrome P-450 epoxygenase metabolites of the n-6 fatty acid arachidonate, and they potently dilate coronary arterioles (Oltman et al., 1998; Zhang et al., 2001) . Because bradykinin and acetylcholine stimulate the endothelial synthesis and release of EETs (Nithipatikom et al., 2000) and because EETs hyperpolarize and relax myocytes in small arteries, EETs have been hypothesized to be endothelial-dependent hyperpolarizing factors (EDHFs) (Campbell et al., 1996; Fisslthaler et al., 1999) . Moreover, like EDHF-induced dilations in human vessels (Urakami-Harasawa et al., 1997) , EET-induced dilations are more prominent in resistance vessels than in conduit vessels (Oltman et al., 1998) . Recently, dietary docosahexaenoate (but not eicosapentaenoate) was found to enhance the blood flow in human arterioles after acetylcholine infusions in the presence of an inhibitor of nitric-oxide synthesis. Thus, dietary docosahexaenoate may enhance the release of an EDHF, perhaps by providing an EDHF precursor (Mori et al., 2000) . Yet, unlike eicosapentaenoate (Needleman et al., 1979; Zhang et al., 2001) , no docosahexaenoate metabolite has been reported to be a potent dilator of resistance vessels.
Early animal studies suggested that EETs hyperpolarized vascular smooth muscle cells through activation of BK Ca channels (Hu and Kim, 1993) . Because of a high density in myocyte membranes and large conductance properties, BK Ca channels are an important determinant of vascular tone. Moreover, primary and secondary alterations in BK Ca channel activities are common in hypertensive rats and mice (Liu et al., 1998; Pluger et al., 2000; Lohn et al., 2001) . Consistent with a generalized activation of vascular BK Ca channels, an increased whole body synthesis of EETs retards hypertension development in several rat models (Capdevila and Falck, 2001) . Similarly, dietary fish oil and docosahexaenoate have hypotensive effects in rat (Hashimoto et al., 1999) and retard the development of hypertension in multiple rat models (McLennan et al., 1996; Frenoux et al., 2001) .
Crude preparations of hepatic and renal cytochrome P-450 epoxygenases react with docosahexaenoate, eicosapentaenoate, and arachidonate to yield multiple EDP, epoxyeicosaquatraenoic (EEQ), and EET regioisomers, respectively, with little apparent substrate specificity (VanRollins et al., 1984 (VanRollins et al., , 1988 . Moreover, a cloned "arachidonate" P-450 epoxygenase binds arachidonate and eicosapentaenoate with equal affinity but generates twice as much EEQ as EET (GrahamLorence et al., 1997) . Thus, like prostaglandins, the epoxides present in tissues may reflect primarily which polyunsaturated fatty acids are available to act as substrate. Interestingly, dietary fish oils cause docosahexaenoate to preferentially accumulate in cardiac tissue (Charnock et al., 1986; Watkins et al., 2001) where polyunsaturated fatty acid cytochrome P-450 epoxygenases are known to reside (Fisslthaler et al., 1999; Tsao et al., 2001) .
In the present study, we tested whether cytochrome P-450 epoxygenase metabolites of docosahexaenoate (EDPs) dilated coronary arterioles and activated BK Ca channels in myocytes from coronary arterioles and small arteries. Dilatory responses in porcine microvessels were examined, because in this species dietary fish oil is known to enhance the endothelial formation of an EDHF (Shimokawa and Vanhoutte, 1989; Nagao et al., 1995) . To determine a mechanism for EDPinduced dilations, the effects of 13,14-EDP on BK Ca channels in inside-out patches from myocytes in porcine coronary arterioles were examined. To compare potencies with EETs, the effects of 13,14-EDP on BK Ca channels in inside-out patches from rat coronary myocytes were investigated . Our findings indicate that cytochrome P-450 metabolites of the n-3 fatty acid docosahexaenoate potently dilate coronary microvessels by activating BK Ca channels in vascular smooth muscle cells.
Materials and Methods
Synthesis of EDPs and 13,14-Dihydroxydocosapentaenoic Acid (DHDP). A mixture of six EDP regioisomers was generated by reacting the methyl ester of [1-
14 C]docosahexaenoic acid with mchloroperoxybenzoic acid that converts cis double bonds to (Ϯ)-cisepoxides (Chung and Scott, 1974) . Individual regioisomers (Fig. 1) were isolated by normal phase-HPLC and collected over ice (VanRollins et al., 1989) . One regioisomer, 4,5-EDP, was not processed further because it is chemically unstable due to ready formation of ␥-lactones. The other five regioisomers (Fig. 1) were saponified and further isolated by normal phase-HPLC (VanRollins et al., 1989) . Based on reversed-phase HPLC (VanRollins et al., 1989) , each isomer was Ͼ99% free of diol hydrolysis artifacts as well as other regioisomers. Molecular weights, epoxide positions, number of double bonds, and absence of conjugated dienes were established using gas chromatography-mass spectrometry and ultraviolet spectroscopy (VanRollins et al., 1989) . In addition, 10 mg of synthetic 13,14-EDP was subjected to acid-catalyzed hydrolysis to yield 13,14-DHDP ( Fig.  1 ) (VanRollins et al., 1989) . A 3.0-g aliquot of the 13,14-DHDP product was derivatized to form a bis(trimethylsilyl) ether, pentafluorobenzylester, and the position of the resulting vicinal diol was confirmed by electron impact, positive-and negative-ion chemical ionization mass spectrometry (VanRollins et al., 1996) .
Isolation and Preparation of Porcine Coronary Microvessels. The animal protocols were approved by the University of Iowa Animal Care and Use Committee and conform with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health. Details for isolating porcine microvessels have been reported (Zhang et al., 2001) . In brief, hearts of seven male (118 Ϯ 10 kg) and 12 female pigs (128 Ϯ 4.4 kg) were harvested at a local slaughterhouse and cooled over ice. After being gently flushed with heparinized Krebs' solution to remove blood, subepicardial arterioles were perfused with an India ink solution for visualization purposes. Individual arterioles [65-135-m range and 94 Ϯ 17 (S.D.) m i.d.; ϳ1.5 mm in length and ϳ16 g of dry weight] were excised under a dissecting microscope and trimmed of fat and adventitia.
Vasoactivity was tested using a pressurized, no-flow arteriole preparation (Zhang et al., 2001) . In brief, each porcine arteriole was cannulated at both ends with glass micropipettes secured by sutures. The micropipettes were connected via tubing containing Krebs' solution to a reservoir whose height was adjusted to maintain an intraluminal pressure of 60 mm Hg. Each microvessel was submerged in an organ chamber through which Krebs' buffer, prewarmed to 37°C and aerated with 20% oxygen, 75% nitrogen, and 5% CO 2 , was continuously circulated. The organ chamber was placed onto the stage of an inverted microscope, to which a video camera, monitor, and calibrated caliper were mounted. Vessel internal diameters were measured by manually adjusting a video micrometer.
Protocol Testing the Potency of Docosahexaenoate, EDPs, and 13,14-DHDP in Dilating Coronary Arterioles. To test arteriole viability, 75 mM isotonic KCl was applied to a vessel preequilibrated at the original in situ length for 30 min at 60 mm Hg luminal pressure. After 5 min, fresh Krebs' solution was added to the chamber and the arteriole diameter was allowed to return to the original baseline value. To test dilatory potency, the arterioles were first constricted to 37 to 61% of the resting diameter using 6.6 Ϯ 3.1 nM (S.D.) endothelin-1 (Phoenix Pharmaceutical, Inc., San Francisco, CA). Docosahexaenoate (10 Ϫ10 -10 Ϫ4 M) or EDPs/13,14-DHDP (10 Ϫ16 -10 Ϫ6 M) were added in increasing concentrations directly to the organ chambers, and dilation responses were determined every 3 min. In a few studies, Krebs' vehicle alone was added to assess the contribution of spontaneous dilation with time. Upon completing each concentration-dilation study, a single dose of 100 M sodium nitroprusside or 100 M papaverine (Sigma-Aldrich, St. Louis, MO) was applied to test residual dilating capacity. In the rare circumstance where a compound produced full-scale dilation, the bath was filled with fresh medium, and a single, repeat dose of endothelin was administered to test whether the vessel was viable and retained the capacity to constrict.
Data were considered unacceptable if arterioles 1) demonstrated obvious leaks, 2) failed to constrict Ͼ30% to 75 mM KCl and Ͼ35% to endothelin, 3) failed to dilate Ͼ80% to 100 M sodium nitroprusside or papaverine, or 4) failed to reconstrict Ͼ30% upon reexposure to endothelin.
Protocol Testing the Stability of Fatty Epoxides in Arteriole Baths. Porcine coronary arterioles (n ϭ 2) were isolated, pressurized, and preconstricted with potassium and endothelin as described above. Each vessel was incubated 37 min (the average application time for 12 doses, each dose requiring a 3-min wait for measuring vasoactivity) with a mixture of 2.0 M 13,14-EDP (unlabeled) and 1.0 M [1-
14 C]11,12-EET (76,000 dpm); the latter tracer was synthesized as described previously (VanRollins et al., 1996) and added to assess hydrolysis specificity. After vessel responses to epoxides and sodium nitroprusside were tested, the 20-ml bath solution was transferred to 80 ml of ice-cold methanol containing ϳ5 mg of Na 2 CO 3 . Each of the vessels studied was considered representative in that they responded appropriately to each of the agonists tested.
After storage at Ϫ84°C overnight, fractions were flash evaporated to near dryness and extracted into ice-cold water-saturated ethyl acetate (VanRollins et al., 1989) . After being concentrated under a nitrogen stream, metabolites were resolved with guard (5 ϫ 0.46 cm) and analytical (25 ϫ 0.46 cm) columns containing 5 m of Luna C18(2) particles (Phenomenex, Torrance, CA) through which 61% acetonitrile and 39% water, pH 2.2, flowed at 1 ml/min and 1600 psig (VanRollins et al., 1996) . Metabolites in the effluent were monitored by absorbance at 194 nm with a photodiode array detector (LC480; PerkinElmer Instruments, Norwalk, CT) and by on-line liquid scintillation counting (model 500TR fitted with extra lead shielding and a 0.5-ml time-resolved liquid scintillation cell; Packard Instrument Company, Inc., Downers Grove, IL). Scintillant cocktail (Ultima-Flo M; Packard Instrument Company, Inc.) was introduced into the cell at 3.63 ml/min. Similar studies without vessels were performed to monitor processing artifacts.
Preparation of Docosahexaenoate, EDP, and 13,14-DHDP Solutions. All solutions were prepared on the day of the experiment. The Krebs' solution consisted of 119.7 mM NaCl, 5 mM KCl, 2.5 mM CaCl 2 , 1.2 mM MgSO 4 , 23.5 mM NaHCO 3 , 1.2 mM KH 2 PO 4 , 0.026 mM Na 2 EDTA, and 11 mM glucose, pH 7.4, and was aerated at room temperature with 20% O 2 , 5% CO 2 , and 75% N 2 . Upon being synthesized, [1- 14 C]EDPs and [1-14 C]13,14-DHDP were stored at 5 mM concentrations for up to 40 days at Ϫ80°C in ethanol. Just before use, EDPs and 13,14-DHDP were subjected to serial dilutions with icecold Krebs' buffer and maintained over ice. The concentrations of the stock solutions and initial dilutions were checked daily by liquid scintillation counting techniques (Zhang et al., 2001 ). The final concentration of ethanol was Ͻ0.01%. In contrast to EDPs and 13,14-DHDP, sodium docosahexaenoate (100 mg of neat material; NuChek Prep, Elysian, MN) was initially suspended in 143 ml of isotonic NaCl solution and briefly stirred at 40°C until dissolved. Serial dilutions were done using a Krebs' buffer maintained at 25°C. No concentration of docosahexaenoate higher than 100 M could be tested for vasoactivity because the high concentrations produced a cloudy Krebs' solution.
Isolation of Smooth Muscle Cells from Porcine Coronary Arterioles and Rat Coronary Small Arteries for Patch-Clamp
Studies. Upon being rapidly excised, five porcine hearts were washed and suspended in a 4°C solution containing 145.0 mM NaCl, 4.0 mM KCl, 0.05 mM CaCl 2 , 1.0 mM MgCl 2 , 10.0 mM HEPES, and 10.0 mM glucose, previously adjusted to pH 7.4 with NaOH. Subepicardial microvessels were isolated under a dissecting microscope, and their diameters (60 -120 m) were measured using a video microscope monitor and micrometer. Single smooth muscle cells were isolated as described previously (Ye et al., 2000) but with modified digestion conditions to improve cell viability. In brief, the microvessels were incubated at 37°C for 35 to 40 min in a Ca 2ϩ -free Tyrode's solution, pH 7.4, containing 0.18% protease (type XXIV; Sigma-Aldrich), 0.15% collagenase (type 1A; Sigma-Aldrich), 0.12% trypsin inhibitor (type II-S; Sigma-Aldrich), 138.0 mM NaCl, 4.5 mM KCl, 0.5 mM MgCl 2 , 0.33 mM Na 2 HPO 4 , 10 mM HEPES, and 5.5 mM glucose. Digested microvessels were washed by three transfers to fresh Krebs' solutions, pH 7.4, composed of 70.0 mM KOH, 70.0 mM KCl, 50.0 mM L-glutamic acid, 20.0 mM taurine, 0.5 mM MgCl 2 , 1.0 mM K 2 HPO 4 , 0.5 mM EGTA, 10.0 mM HEPES, 5.0 mM creatine, 5.0 mM pyruvic acid, and 5.0 mM Na 2 ATP. Single smooth muscle cells were isolated by triturating with a fire-polished glass pipette, stored at 4°C in the Krebs' solution, and used within 10 h.
To compare EDP and EET potencies, smooth muscle cells in small arteries were isolated from hearts of rats. In brief, male SpragueDawley rats (250 -300 g) were anesthetized by inhaling methoxyfluorane. Hearts were rapidly excised and placed in a basal, physiological saline solution containing 145.0 mM NaCl, 4.0 mM KCl, 0.05 mM CaCl 2 , 1.0 mM MgCl 2 , 10.0 mM HEPES, and 10.0 mM glucose, and adjusted to pH 7.2 with NaOH. After being isolated under a dissection microscope, the secondary and tertiary branches (150 -300 m i.d.) of the septal coronary arteries were incubated at 37°C for 10 min in 1.0 ml of basal solution containing 0.1% bovine serum albumin. Initially, vessels were enzymatically digested 10 min at 37°C in 1.0 ml of fresh basal solution containing 1.5 mg of papain (11.9 units mg Ϫ1 ; Sigma-Aldrich) and 1.0 mg of dithiothreitol (Roche Applied Sciences, Indianapolis, IN). The vessels were further digested 10 min at 37°C in 1.0 ml of fresh basal solution containing 1.0 mg of collagenase (CLS-2, 364 units mg Ϫ1 ; Worthington Biochemicals, Lakewood, NJ) and 1.0 mg of trypsin inhibitor (type II-S; Sigma-Aldrich). To remove the exogenous enzymes, each vessel was transferred three times to 1.0 ml of fresh basal solution, and gently triturated with a fire-polished glass pipette until completely dissociated. The resulting smooth muscle cell suspension was stored at 4°C and used within 8 h.
Single BK Ca Channel Recording. Unitary membrane currents in individual smooth muscle cells were recorded using a patch-clamp technique in an inside-out configuration (Hamill et al., 1981) . In brief, isolated vascular smooth muscle cells were placed in a 1.0-ml chamber on the stage of an inverted microscope (CK 40; Olympus America Inc., Mellville, NY) and were superfused at 1 to 2 ml min Ϫ1 using a direct current-powered pump (model 700; Instech Laboratories, Inc., Plymouth Meeting, PA). Under these conditions, the bath solution was entirely replaced within 30 to 60 s. Borosilicate glass capillaries (Corning 7056; Warner Instrument, Hamden, CT) were used to fabricate patch pipettes. When filled with 140.0 mM KCl, 1.0 mM CaCl 2 , 1.0 mM MgCl 2 , 10.0 mM HEPES, and 1.0 mM EGTA, and adjusted to pH 7.4 with KOH, each electrode had a tip resistance between 4 and 10 M⍀ and a typical seal resistance greater than 10 G⍀. Single BK Ca channel currents were recorded with an Axopatch 200B integrating amplifier (Axon Instruments, Union City, CA), and the output of the amplifier was filtered through an eight-pole low pass Bessel filter unit (900B/9L8L; Frequency Devices, Haverhill, MA) at 5 kHz and digitized at 20 (pig) or 40 (rat) kHz (12-bit resolution, Digidata 1200; Axon Instruments). Software (pClamp, version 6.05; Axon Instruments) was used to generate the voltageclamp protocols, and the resulting current recordings were stored in a Pentium-based personal computer (Dimension XPS T450; Dell Computer Corp., Round Rock, TX) for further analysis. A pStat program, implemented in the pClamp software, was later used to calculate the BK Ca channel open probability (P o ):
where P o is the single channel open probability, T is the duration of recording, t j is the time spent with j ϭ 1,2,. . . . . . N channel openings, and N is the maximal number of simultaneous channel openings observed when P o was high. An N not more than five was used for all P o studies. Each dose-response curve was fitted using a Hill equation of the following form:
H }, where P o,max represents the maximal channel activity observed, S represents concentration of the chemical, EC 50 represents the concentration at half-maximal effect, and H is the Hill coefficient.
For each BK Ca channel study, the membrane potential of the patches was held at ϩ60 mV and the (cytosolic) perfusate was maintained at 21-23°C. The perfusate contained 140.0 mM KCl, 1.0 mM MgCl 2 , 10.0 mM HEPES plus 1.0 mM EGTA and was adjusted to pH 7.35 with KOH. Enough CaCl 2 was added to provide either 0.2 M (pig) or 1.0 (rat) M free Ca 2ϩ , as calculated using Chelator software (Theo J. M. Schoenmakers, Department of Animal Physiology, University of Nijmagen, Toernooiveld, The Netherlands). After excising each patch, we routinely examined channel sensitivity to Ca 2ϩ by removing and replenishing Ca 2ϩ in the bath solution. Only patches containing BK Ca channels sensitive to Ca 2ϩ were studied further. Individual BK Ca channels were further identified by unitary conductance, voltage sensitivity, and by inhibition with 50 to 100 nM iberiotoxin. Details on BK Ca measurements are available .
To test BK Ca activation, 13,14-EDP and docosahexaenoate were prepared in absolute ethanol as 2.9 to 5.0 and 50 mM stock solutions, respectively, and stored under nitrogen at Ϫ80°C. On the day of the experiment, 13,14-EDP and docosahexaenoate were serially diluted with bath solution and added to the perfusate; the final ethanol concentration was less than 0.0002%.
Statistical Analysis. Data are presented as mean Ϯ S.E.M. values unless otherwise stated. Concentration-dilation curves were subjected to a nonlinear regression program (Prism version 3.0; GraphPad Software, San Diego, CA). From each fitted curve, Hill slope and concentrations that produced maximal dilation and 50% of maximal vasodilation (EC 50 ) were determined and evaluated using one-way analysis of variance followed by a Fisher correction (least significant difference) for multiple comparisons. Whether the maximal dilation was less than that induced by sodium nitroprusside was assessed using a one-tailed paired t test. Changes in P o were evaluated using one-way analysis of variance and the Student's t test. In all studies, a p value of Ͻ0.05 was considered statistically significant.
Results
Each of the five EDP regioisomers dilated porcine arterioles in a concentration-dependent manner (Fig. 2A) . , 16, 13, 10, and 7, respectively (Table 1) . The dilations were thus 50% complete for EDP concentrations ranging from 1.6 to 211 pM. No EDP regiospecificity was detectable in the induced dilations. In contrast to the EDPs, the EC 50 for the diol 13,14-DHDP was 30 Ϯ 22 nM (n ϭ 7). Thus, the conversion of 13,14-EDP to 13,14-DHDP caused a 15,000-fold loss in potency (p Ͻ 0.001). As an estimate of minimal detectable responses for curves characterized by low Hill slopes (vide infra), the EC 20 values were 1960 Ϯ 1630, 501 Ϯ 403, 150 Ϯ 132, 552 Ϯ 240, and 199 Ϯ 147 fM for 19,20-, 16,17-, 13,14-, 10,11-, and 7,8-EDP, respectively. Dilated arterioles were detectable at EDP concentrations ranging from 150 fM to 1.96 pM. Thus, EDPs were very potent dilators, with some in dilating porcine coronary arterioles. Arterioles were constricted with endothelin to 35 to 60% of their resting diameters, and EDPs (A) or docosahexaenoate (B) were applied to the medium in an accumulative concentration manner. Vessel dilation was measured using a microscope interfaced to a video micrometer. The highest vehicle concentration applied produced a maximum dilation of 16 Ϯ 5% (n ϭ 6). At the completion of each experiment, sodium nitroprusside (SNP) was added to the vessel medium to test for residual smooth muscle responsiveness. Data are the mean percentage Ϯ S.E.M. of the diameter change induced by endothelin, and n is the number of animals studied.
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Each of the five EDP regioisomers produced slightly less than the maximal dilation induced by 100 M sodium nitroprusside (Table 1) . 13,14-EDP reached 93% of the dilation induced by sodium nitroprusside; however, the other four EDPs produced only 84 Ϯ 2% of the maximal possible dilation. Therefore, at nanomolar concentrations all EDPs induced dilations that were 7 to 16% less than the maximal response produced by sodium nitroprusside (Fig. 2A) . Interestingly, the maximal dilations were reached only after increasing the EDP concentration over 6 orders of magnitude. The Hill slope was always Յ0.6 and showed no regiospecificity (Table 1) . Nevertheless, together the above-mentioned data indicated that EDPs were both highly potent and efficacious dilators of coronary arterioles.
Docosahexaenoate also dilated porcine subepicardial arterioles in a concentration-dependent manner (Fig. 2B) . However, because of solubility problems at greater than 100 M, the maximal response achieved for docosahexaenoate was only 80 Ϯ 9% and was less than the 102 Ϯ 2% obtained with sodium nitroprusside (p ϭ 0.023). Perhaps more importantly, the apparent EC 50 of docosahexaenoate was 8.4 Ϯ 2.6 M and no dilation was detectable at less than 100 nM. Thus, the parent docosahexaenoate was 100,000 times less potent in dilating coronary arterioles than the EDP metabolites that had an average EC 50 of 48 pM.
Upon being added to the arteriole bath, 13,14-EDP underwent little hydrolysis over a 37-min period. Based on integration of absorbance at 194 nm, only 1.6 and 2.8% (n ϭ 2) of 2.0 M 13,14-EDP were converted to 13,14-DHDP, which eluted at 12.97 min (Fig. 3A, bottom) . Based on integration of radioactivity, only 1.1 and 2.8% of [1-14 C]11,12-EET were converted to [1-14 C]11,12-DHET, which eluted at 13.40 min (Fig. 3A, top) . Because the starting concentration for 11,12-EET (1.0 M) was one-half that of 13,14-EDP (2.0 M) and because EETs and DHETS have much lower absorbances than EDPs and DHDPs (Fig. 3B, bottom) , the small amount of 11,12-DHET generated was not readily detectable at 194 Values are geometrical means percentage Ϯ S.E. of the diameter change induced by endothelin. The extent that endothelin had preconstricted porcine arterioles was 42 Ϯ 3, 52 Ϯ 3, 49 Ϯ 3, 39 Ϯ 1, and 48 Ϯ 3% of the resting vessel diameter for 19, 16, 13, 10, and 7, respectively. EC 50 represents the concentration producing 50% of maximal vasodilation. The R 2 of individual curve fittings averaged 0.982 Ϯ 0.016 (S.D., n ϭ 27), and ranged from 0.968 Ϯ 0.021 (n ϭ 6) to 0.990 Ϯ 0.007 (n ϭ 6) in the five studies.
EDP Isomer
Log EC (Fig. 3A, bottom) . Interestingly, the total radioactivity recovered was only 40 and 44% of that applied but was similar to the 46 and 50% recovered from baths without arterioles. Perhaps more importantly, the ultraviolet absorbing compounds that eluted at 38.4 and 46.2 min were not 13,14-EDP metabolites but contaminants of the extracting solvents. Together, the above-mentioned data indicate that both 13,14-EDP and 11,12-EET were stable for 37 min during incubations in the arteriole baths.
One accepted mechanism mediating dilations induced by EETs-cytochrome P-450 epoxygenase metabolites of the n-6 fatty acid arachidonate involves activations of BK Ca channels and hyperpolarization of coronary smooth muscle cells (for review, see Zhang et al., 2001) . Like EETs ), 13,14-EDP also activated BK Ca channels in myocytes from porcine coronary arterioles in a dose-dependent manner. Increasing the concentration of 13,14-EDP recruited more and more BK Ca channels (Fig. 4A ). Under these experimental conditions, the ethanol vehicle had a maximum concentration of 0.0002% and did not activate BK Ca channels. Channel recruitment by 13,14-EDP was associated with an increased open probability for BK Ca channels (Fig. 4B) . The open probability increased from 0.062 Ϯ 0.022 (no EDP) to a maximum of 0.34 Ϯ 0.09 (100 pM 13,14-EDP). Open probability climbed 6.04 Ϯ 1.03 fold (p ϭ 0.02) when calculated for each experiment, and 5.5-fold when means were compared. Perhaps more germane for mechanism considerations, the EC 50 of BK Ca channel activation was 6.6 Ϯ 0.6 pM (n ϭ 5), and although statistically different (p ϭ 0.017), was comparable with the 2 pM EC 50 observed for coronary arteriolar dilation. The Hill coefficient for BK Ca channel activation was 1.1. In contrast, the Hill coefficient for arteriolar dilation was only 0.429 (Table 1) . Thus, in the same arteriolar vessel, BK Ca channel activation and dilations had the same EC 50 but different Hill coefficients. To our knowledge, this is the first report on eicosanoid potencies and BK Ca channel activity in porcine coronary arterioles.
Because of the surprisingly high potency of 13,14-EDP in activating BK Ca channels in myocytes from porcine arterioles, the effects of 13,14-EDP on BK Ca channels in myocytes from rat small coronary arteries were also studied. Although less sensitive to calcium, the BK channels in rat coronary arteries and their responses to EETs/DHETs have been well characterized . As with porcine arterioles, the BK Ca channels in rat coronary arteries were activated by 13,14-EDP in a dose-dependent manner. Moreover, increasing the concentration of 13,14-EDP recruited more and more BK Ca channels (Fig. 5A, top) . The channel recruitment by 13,14-EDP was associated with an increased probability of opening the BK Ca channels (Fig. 5A, bottom) , which climbed from 0.058 Ϯ 0.026 (no EDP) to a maximum of 0.23 Ϯ 0.05 (100 pM 13,14-EDP). Open probability increased 3.6 Ϯ 0.4-fold (p ϭ 0.02) when calculated for each experiment and 4.0-fold when means were compared. Perhaps more importantly, the EC 50 of BK Ca channel activation was 2.2 Ϯ 0.6 pM (n ϭ 7) and similar (but statistically different, p ϭ 0.001) to Fig. 4 . 13,14-EDP activated BK Ca channels in myocytes from porcine coronary arterioles. Single BK Ca channel currents were recorded on inside-out membrane patches, maintained at ϩ60 mV membrane potential and in the presence of 200 nM cytosolic free Ca 2ϩ . A, raw tracings of BK Ca channels with 15 pA currents that were exposed to increasing concentrations of 13,14-EDP (0, 0.1 pM, 10 pM, and 1 nM); c, current level observed for closed channels. B, after normalizing for different channel numbers in each patch, the P o of BK Ca channels was plotted as a function of increasing concentrations of 13,14-EDP. Data represent mean P o /P o,max values Ϯ S.E.M. (n ϭ 5). In addition, 13,14-EDT data were fitted to a Hill equation; the EC 50 value represents the EDP concentration at half-maximal effect, and H represents the Hill coefficient. Fig. 5 . 13,14-EDP (A) but not docosahexaenoate (B) activated BK Ca channels in myocytes from rat small coronary arteries. Single BK Ca channel currents were recorded as described in Fig. 4 , but in the presence of 1 M cytosolic free Ca 2ϩ . Top, raw tracings of BK Ca channels with 15-pA currents that were exposed to increasing concentrations of 13,14-EDP (A) and docosahexaenoate (B). Bottom, normalized P o of BK Ca channels was plotted as a function of increasing concentrations of 13,14-EDP (A) or docosahexaenoate (B). Data represent mean P o values Ϯ S.E.M. (n ϭ 7).
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at ASPET Journals on April 4, 2017 jpet.aspetjournals.org Downloaded from the 6.6 Ϯ 0.6 pM (n ϭ 5) found for porcine arterioles. Because the 1.5 Hill coefficient found for rat myocytes was similar to the 1.1 (p ϭ 0.15) observed for porcine myocytes, there were only minor differences in BK Ca channel responsiveness to 13,14-EDP by myocytes from rat small arteries and porcine arterioles. More importantly, 13,14-EDP was a highly potent channel activator in both preparations.
Compared with 13,14-EDP, docosahexaenoate weakly activated BK Ca channels (Fig. 5B, top) . In fact, up to 10 M docosahexaenoate (Fig. 5B, bottom) completely failed to activate BK Ca channels (n ϭ 7; p ϭ 0.350). In contrast, vessel dilations were apparent at 1 M docosahexaenoate (Fig. 2B) . Thus, docosahexaenoate weakly dilated coronary arterioles at concentrations that had no effect on the BK Ca channels in myocytes isolated from small coronary arteries.
Discussion
In the present report, femtomolar-to-picomolar concentrations of EDPs dilated 65 to 135-m-i.d. porcine coronary arterioles. The EC 50 values ranged from 1.6 to 211 pM. As found for coronary arteriolar dilations induced by epoxides of arachidonate (EETs) and eicosapentaenoate (EEQs), EDPinduced dilations were not regioselective. Moreover, the EC 50 value for individual EDPs was very similar to that of individual regioisomers derived from eicosapentaenoate and arachidonate (Zhang et al., 2001) . Like 11,12-EET, 13,14-EDP underwent little hydrolysis during the time that a dilation was induced (Ϸ0.25%/3 min). Thus, compared with endothelial cells isolated from large arteries (VanRollins et al., 1996) , whole arterioles and endothelial cells from microvessels (M. VanRollins, unpublished data) may have little epoxide hydrolase activity. Interestingly, unlike 11,12-EET (Oltman et al., 1998) , 13,14-EDP hydrolysis dramatically lowered the potency for arteriolar dilation. Together, these findings indicate that EDPs are some of the most potent dilators of coronary microvessels known and suggest that the induced dilations do not require prior conversions to diols.
In contrast to EDPs, the parent docosahexaenoate was only a weak dilator of coronary microvessels. The EC 50 value for docosahexaenoate-induced dilations was 8.4 Ϯ 2.6 M and was greater than that of arachidonate (0.48 Ϯ 0.19 M; n ϭ 14) prepared and administered under identical conditions (p ϭ 0.0003). Accordingly, docosahexaenoate was 16-and 160,000-fold less potent than arachidonate and EDPs, respectively, in dilating coronary arterioles. One explanation for the low dilator potency is that the abluminally presented docosahexaenoate must first penetrate the smooth muscle barrier, enter endothelial cells for epoxygenation, and be released as vasodilatory EDPs. If EDP formation mediates the docosahexaenoate-induced dilations, the marked differences in potencies between EDPs and docosahexaenoate suggest that only a small amount of newly formed EDP is released to relax underlying smooth muscle cells and dilate whole arterioles.
13,14-EDP potently activated BK Ca channels in coronary myocytes from porcine arterioles and rat small arteries. Unlike other preparations (Li and Campbell, 1997) , the porcine and rat inside-out patch preparations are similar in that they require no GTP to demonstrate BK Ca channel activation by fatty epoxides and diols . Moreover, the channels responded similarly to 13,14-EDP, generating comparable EC 50 values and maximum channel open probabilities. Yet, the patch preparations differed in that a similar state of activation occurred in the arterioles at 5-fold lower cytosolic calcium concentrations than used for small arteries. Such a difference in calcium sensitivity suggests the presence of BK Ca channel isoforms, which may be either vessel-or species-specific. Unfortunately, characterizing and identifying the different isoforms require the analysis of large numbers of channels (Toro et al., 1998) . Moreover, quantitating the different proportions of isoforms in coronary conduits and arterioles awaits the advent of specific antibodies. Both goals are beyond the scope of the present investigation. Perhaps more important regarding whether EDPs act as EDHFs, the measured EC 50 for 13,14-EDP activation of BK Ca channels was 1000-fold less than reported for epoxides and diols derived from the n-6 fatty acid arachidonate when analyzed under identical conditions Zhang et al., 2001) . Thus, EDPs are the most potent fatty acid epoxides known to activate BK Ca channels Zhang et al., 2001 ). In fact, we are unaware of any BK Ca channel activator as potent as 13,14-EDP.
In concentrations up to 10 M, docosahexaenoate did not activate BK Ca channels in the smooth muscle cells from coronary small arteries. Moreover, when prepared and administered under identical conditions, arachidonate does not activate BK Ca channels . In light of the comparable EDP potencies for activating the BK Ca channels in myocytes from porcine arteriolar and rat small arteries, docosahexaenoate was probably a poor activator of arteriolar BK Ca channels. Assuming a comparable deficiency in BK Ca channel activation in porcine arterioles as found in rat small arteries, there would not be significant BK Ca channel activation at the docosahexaenoate doses (EC 50 value of Ϸ8.4 M) that induce arteriolar dilations. As mentioned above, the weak dilations in whole arterioles may be readily explained by cytochrome P-450 epoxygenases in endothelial cells converting a small amount of docosahexaenoate to EDPs. 13,14-EDP is a highly potent activator of BK Ca channels in porcine arterioles, and at least 10,000,000-fold more potent than docosahexaenoate in activating the BK Ca channels in small arteries. The inability of either docosahexaenoate or arachidonate to activate BK Ca channels may result from the plasmalemmal patches lacking the biosynthetic machinery (cytochrome P-450 epoxygenases) for converting polyunsaturated fatty acids to epoxides. In any case, it is clear that cytochrome P-450 epoxygenases transform docosahexanoate to very potent coronary vasodilators, BK Ca channel activators, and inhibitors of platelet aggregation (VanRollins, 1995) . All three actions may contribute to the antithrombotic effects of fish and fish oil diets.
Regarding the mechanism of action for EDP-induced dilations, the EC 50 value of 13,14-EDP for activating BK Ca channels matched that of arteriolar dilation. Moreover, a tendency to activate channels in the femtomolar range was indicated (Fig. 4B) . Both findings suggested that BK Ca channel activation is the predominant mechanism for EDP-induced dilations. In contrast, the EC 50 values for BK Ca channel activation by arachidonate epoxides/diols are orders of magnitude greater than those for dilations Zhang et al., 2001) , even when the same vessel from the same species is examined (Zou et al., 1996) . Such a disparity in EC 50 values suggests that activation of potassium channels other than BK Ca channels may mediate the arteriolar dilations induced by epoxides and diols derived from arachidonate (Zhang et al., 2001 ). Thus, unlike EET vasoactivity, EDP-induced dilations may be mediated exclusively by BK Ca channel activation.
However, the molecular mechanisms responsible for EDPinduced dilations are more complex than suggested by simply matching dilation EC 50 values with those of BK Ca channel activation. Cytoplasmic elements are absent from patches in the inside-out configuration; in such simple plasmalemmal preparations, the EDPs seem to act by directly binding to the BK Ca channels or their immediate environs. The open probability responses of the coronary channels had Hill slopes of 1.1 (pig) and 1.5 (rat) and indicate that BK channels may possess one or two EDP binding sites. Thus, in the rat small arteries, the EDPs may bind on or close to the ␣-pores or ␤-regulatory units of BK Ca channels and, by hydrogen bonding with the epoxide ring, induce conformational changes favoring EDP binding to a second site Zhang et al., 2001) . Future binding studies with cloned BK Ca channels and site-directed mutagenesis are needed to clarify the precise binding sites. Surprisingly, arteriolar dilations by fatty epoxides are characterized by Hill slopes less than 1.0. The Hill slope determined for dilations by 13,14-EDP was 0.429, and the average Hill slope for the five EDP regioisomers was 0.52 Ϯ 0.04 (n ϭ 5). In comparison, the dilation curves of arachidonate-and eicosapentaenoate-derived epoxides had Hill slopes of 0.32 Ϯ 0.02 (n ϭ 6 enantiomers) and 0.39 Ϯ 0.02 (n ϭ 4), respectively (Zhang et al., 2001 ). Thus, EDP-dilation curves had Hill slopes that are 33% (p Ͻ 0.05) and 62% (p Ͻ 0.001) greater than that of arachidonate and eicosapentaenoate epoxides, respectively. Notwithstanding, the Hill slope for arteriolar dilation by 13,14-EDP was only one-third the 1.1 value measured for BK Ca channel activation. One possible explanation for the consistently low Hill slopes characterizing arteriolar dilations is that fatty epoxides interact with G proteins of limited availability in intact vessels, and thus inhibit subsequent EDP binding (Li and Campbell, 1997) . Alternatively, the threshold activities of fatty epoxides may result from interactions with several BK Ca channel isoforms of varying affinities or with other (non-BK Ca ) potassium channels. In any case, the fatty epoxide interactions with BK Ca channels in whole arterioles seem to involve more than a simple, direct interaction with BK Ca channels.
In conclusion, EDPs are cytochrome P-450 epoxygenase metabolites of docosahexaenoate, one of the major n-3 fatty acids in fish oils. In the present study, 13,14-EDP activated BK Ca channels with an EC 50 value of 2.2 to 6.6 pM, which is over 1000 times more potent than observed for epoxides (EETs)/diols (DHETs) derived from arachidonate. To our knowledge, no cyclooxygenase or lipoxygenase metabolite of n-3 fatty acids has been reported to be more active than the corresponding n-6 fatty acid product. As a result of the potent BK Ca channel activation by 13,14-EDP, hyperpolarization and relaxation of vascular smooth muscle cells should follow. Consistent with this expectation, 13,14-EDP dilated coronary arterioles with an EC 50 value of 2 pM. EDPs are the first docosahexaenoate metabolites shown to have potent dilator actions on resistance vessels. Moreover, the EDHF-like actions make it an important goal to determine whether EDPs are synthesized and released from vascular endothelial cells in response to bradykinin and acetylcholine. An endothelial release of EDPs could explain the enhanced endothelial-dependent relaxations and hypotensive effects that accompany dietary supplements of docosahexaenoate. In addition, we speculate that an enhanced release of EDPs and EEQs may mediate reductions in myocardial infarctions (Tavani et al., 2001 ) and ischemia-induced arrhythmias associated with dietary fish oils (Leaf, 2001) .
